These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1417902)

  • 1. Effect of Helicobacter pylori lipopolysaccharide on the synthesis of sulfated gastric mucin.
    Slomiany BL; Liau YH; Lopez RA; Piotrowski J; Czajkowski A; Slomiany A
    Biochem Int; 1992 Aug; 27(4):687-97. PubMed ID: 1417902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicobacter pylori lipopolysaccharide effect on the synthesis and secretion of gastric sulfomucin.
    Liau YH; Lopez RA; Slomiany A; Slomiany BL
    Biochem Biophys Res Commun; 1992 May; 184(3):1411-7. PubMed ID: 1590801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of sulfation in the processing of gastric mucins.
    Liau YH; Murty VL; Slomiany A; Bielanski W; Slomiany BL
    J Physiol Pharmacol; 1991 Dec; 42(4):357-66. PubMed ID: 1726711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of gastric mucosal mucin receptor by Helicobacter pylori lipopolysaccharide.
    Piotrowski J; Slomiany A; Slomiany BL
    Biochem Mol Biol Int; 1993 Dec; 31(6):1051-8. PubMed ID: 7514919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sucralfate counteracts the inhibition of gastric mucosal mucin receptor by Helicobacter pylori lipopolysaccharide.
    Slomiany A; Piotrowski J; Slomiany BL
    Scand J Gastroenterol Suppl; 1995; 210():77-81. PubMed ID: 8578214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipopolysaccharide a virulence factor of Helicobacter pylori: effect of antiulcer agents.
    Piotrowski J
    J Physiol Pharmacol; 1998 Mar; 49(1):3-24. PubMed ID: 9594407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of gastric mucosal laminin receptor by Helicobacter pylori lipopolysaccharide: effect of ebrotidine.
    Piotrowski J; Morita M; Slomiany A; Slomiany BL
    Biochem Int; 1992 Jun; 27(1):131-8. PubMed ID: 1385705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and secretion of gastric sulfomucin in the presence of ebrotidine, a new antiulcer agent.
    Slomiany BL; Lopez RA; Slomiany A
    Biochem Int; 1992 Dec; 28(4):665-74. PubMed ID: 1482403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter pylori lipopolysaccharide inhibits acid secretion in pylorus-ligated conscious rats.
    Ootsubo C; Okumura T; Takahashi N; Wakebe H; Imagawa K; Kikuchi M; Kohgo Y
    Biochem Biophys Res Commun; 1997 Jul; 236(2):532-7. PubMed ID: 9240475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori lipopolysaccharide inhibition of gastric mucosal somatostatin receptor.
    Piotrowski J; Majka J; Slomiany A; Slomiany BL
    Biochem Mol Biol Int; 1995 Jul; 36(3):491-8. PubMed ID: 7549946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosulfatase activity of H. pylori toward human gastric mucin: effect of sucralfate.
    Slomiany BL; Murty VL; Piotrowski J; Grabska M; Slomiany A
    Am J Gastroenterol; 1992 Sep; 87(9):1132-7. PubMed ID: 1381553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-activating factor mediates Helicobacter pylori lipopolysaccharide interference with gastric mucin synthesis.
    Slomiany BL; Slomiany A
    IUBMB Life; 2004 Jan; 56(1):41-6. PubMed ID: 14992379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of endothelin-1 in gastric mucosal inflammatory responses to Helicobacter pylori Lipopolysaccharide: effect of omeprazole and sucralfate.
    Slomiany BL; Piotrowski J; Slomiany A
    J Physiol Pharmacol; 2000 Jun; 51(2):179-92. PubMed ID: 10898092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of gastric mucosal laminin receptor by Helicobacter pylori lipopolysaccharide: effect of sucralfate.
    Piotrowski J; Yamaki K; Slomiany A; Slomiany BL
    Am J Gastroenterol; 1991 Dec; 86(12):1756-60. PubMed ID: 1835819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide by aspirin but not indomethacin.
    Slomiany BL; Piotrowski J; Slomiany A
    J Endotoxin Res; 2001; 7(3):203-9. PubMed ID: 11581571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycosulfatase activity of Helicobacter pylori towards gastric sulfomucin: effect of nitecapone.
    Slomiany BL; Murty VL; Piotrowski J; Morita M; Slomiany A
    J Physiol Pharmacol; 1993 Mar; 44(1):7-16. PubMed ID: 8518427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Helicobacter pylori activities of ebrotidine. A review of biochemical and animal experimental studies and data.
    Slomiany BL; Piotrowski J; Slomiany A
    Arzneimittelforschung; 1997 Apr; 47(4A):475-82. PubMed ID: 9205747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Helicobacter pylori colonization by sulfated gastric mucin.
    Piotrowski J; Slomiany A; Murty VL; Fekete Z; Slomiany BL
    Biochem Int; 1991 Jul; 24(4):749-56. PubMed ID: 1799374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ebrotidine on the synthesis and secretion of gastric sulfomucin.
    Slomiany BL; Lopez RA; Liau YH; Slomiany A
    Gen Pharmacol; 1993 May; 24(3):611-7. PubMed ID: 8365641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impedance of Helicobacter pylori lipopolysaccharide interference with gastric mucin synthesis by peroxisome proliferator-activated receptor gamma activation involves phosphatidylinositol 3-kinase/ERK pathway.
    Slomiany BL; Slomiany A
    IUBMB Life; 2003 Feb; 55(2):97-102. PubMed ID: 12749691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.